Jiacong Xiao

575 total citations · 1 hit paper
19 papers, 389 citations indexed

About

Jiacong Xiao is a scholar working on Molecular Biology, Rheumatology and Pharmacology. According to data from OpenAlex, Jiacong Xiao has authored 19 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Rheumatology and 5 papers in Pharmacology. Recurrent topics in Jiacong Xiao's work include Osteoarthritis Treatment and Mechanisms (7 papers), Bone Metabolism and Diseases (5 papers) and Inflammasome and immune disorders (4 papers). Jiacong Xiao is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Bone Metabolism and Diseases (5 papers) and Inflammasome and immune disorders (4 papers). Jiacong Xiao collaborates with scholars based in China, Switzerland and United States. Jiacong Xiao's co-authors include Haibin Wang, Zhaofeng Pan, Junzheng Yang, Shaocong Li, Bai‐Hao Chen, Peng Chen, Qi He, Gangyu Zhang, Zihao Wang and Jiaxu Zeng and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Ethnopharmacology.

In The Last Decade

Jiacong Xiao

19 papers receiving 387 citations

Hit Papers

Biochanin A protects against iron overload associated kne... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiacong Xiao China 9 242 122 95 83 42 19 389
Zhaofeng Pan China 9 255 1.1× 124 1.0× 93 1.0× 83 1.0× 45 1.1× 16 402
Qi He China 8 226 0.9× 101 0.8× 59 0.6× 96 1.2× 30 0.7× 19 359
Naiqiang Zhu China 10 168 0.7× 82 0.7× 56 0.6× 50 0.6× 37 0.9× 17 303
Zhuangzhuang Jin China 9 187 0.8× 61 0.5× 155 1.6× 28 0.3× 50 1.2× 14 376
Mingzhi Gong China 12 193 0.8× 131 1.1× 52 0.5× 31 0.4× 25 0.6× 30 438
Xiaofei Feng China 12 218 0.9× 71 0.6× 36 0.4× 61 0.7× 30 0.7× 31 458
Shengyu Cui China 13 261 1.1× 126 1.0× 33 0.3× 21 0.3× 20 0.5× 31 407
Jingting Xu China 8 282 1.2× 206 1.7× 91 1.0× 177 2.1× 40 1.0× 11 437
Jidong Yan China 14 321 1.3× 210 1.7× 53 0.6× 27 0.3× 29 0.7× 31 580

Countries citing papers authored by Jiacong Xiao

Since Specialization
Citations

This map shows the geographic impact of Jiacong Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiacong Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiacong Xiao more than expected).

Fields of papers citing papers by Jiacong Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiacong Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiacong Xiao. The network helps show where Jiacong Xiao may publish in the future.

Co-authorship network of co-authors of Jiacong Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiacong Xiao. A scholar is included among the top collaborators of Jiacong Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiacong Xiao. Jiacong Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Xiao, Jiacong, et al.. (2025). Arctiin alleviates the progression of osteoarthritis by regulating the cholesterol metabolic pathway. Scientific Reports. 15(1). 263–263. 2 indexed citations
3.
Chen, Weijian, Jiacong Xiao, Yi Zhou, et al.. (2024). Curcumenol regulates Histone H3K27me3 demethylases KDM6B affecting Succinic acid metabolism to alleviate cartilage degeneration in knee osteoarthritis. Phytomedicine. 133. 155922–155922. 8 indexed citations
4.
Xiao, Jiacong, Qi He, Zhaofeng Pan, et al.. (2024). Picroside II suppresses chondrocyte pyroptosis through MAPK/NF-κB/NLRP3 signaling pathway alleviates osteoarthritis. PLoS ONE. 19(8). e0308731–e0308731. 4 indexed citations
5.
Yang, Junzheng, Delong Chen, Qi He, et al.. (2024). Arctiin alleviates knee osteoarthritis by suppressing chondrocyte oxidative stress induced by accumulated iron via AKT/NRF2/HO-1 signaling pathway. Scientific Reports. 14(1). 31935–31935. 4 indexed citations
6.
Li, Miao, Jiacong Xiao, Bai‐Hao Chen, et al.. (2024). Loganin inhibits the ROS-NLRP3-IL-1β axis by activating the NRF2/HO-1 pathway against osteoarthritis. Chinese Journal of Natural Medicines. 22(11). 977–990. 1 indexed citations
7.
Chen, Chuyi, Bohao Chen, Qi He, et al.. (2024). Cardamonin attenuates iron overload-induced osteoblast oxidative stress through the HIF-1α/ROS pathway. International Immunopharmacology. 142(Pt A). 112893–112893. 8 indexed citations
8.
He, Qi, Junzheng Yang, Weijian Chen, et al.. (2024). Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation. BMC Complementary Medicine and Therapies. 24(1). 24–24. 6 indexed citations
10.
Li, Miao, Zhaofeng Pan, Qi He, et al.. (2023). Arctiin attenuates iron overload‑induced osteoporosis by regulating the PI3K/Akt pathway. International Journal of Molecular Medicine. 52(5). 6 indexed citations
11.
Li, Shaocong, Qi He, Bai‐Hao Chen, et al.. (2023). Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway. Scientific Reports. 13(1). 13744–13744. 18 indexed citations
12.
Chen, Bohao, Qi He, Chuyi Chen, et al.. (2023). Combination of curcumin and catalase protects against chondrocyte injury and knee osteoarthritis progression by suppressing oxidative stress. Biomedicine & Pharmacotherapy. 168. 115751–115751. 29 indexed citations
13.
He, Qi, Dawei Gong, Jiacong Xiao, et al.. (2023). Myricitrin promotes osteogenesis and prevents ovariectomy bone mass loss via the PI3K/AKT signalling pathway. Journal of Cellular Biochemistry. 124(8). 1155–1172. 4 indexed citations
14.
Xiao, Jiacong, Gangyu Zhang, Bohao Chen, et al.. (2023). Quercetin protects against iron overload-induced osteoporosis through activating the Nrf2/HO-1 pathway. Life Sciences. 322. 121326–121326. 38 indexed citations
15.
Xiao, Jiacong, Gangyu Zhang, Qi He, et al.. (2022). Bioinformatics analysis combined with experimental validation to explore the mechanism of XianLing GuBao capsule against osteoarthritis. Journal of Ethnopharmacology. 294. 115292–115292. 14 indexed citations
16.
Chen, Bohao, Qi He, Junzheng Yang, et al.. (2022). Metformin suppresses Oxidative Stress induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis. Life Sciences. 312. 121092–121092. 36 indexed citations
17.
Pan, Zhaofeng, Qi He, Jiaxu Zeng, et al.. (2022). Naringenin protects against iron overload-induced osteoarthritis by suppressing oxidative stress. Phytomedicine. 105. 154330–154330. 53 indexed citations
18.
He, Qi, Junzheng Yang, Zhaofeng Pan, et al.. (2022). Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2/System xc-/GPX4 axis. Biomedicine & Pharmacotherapy. 157. 113915–113915. 149 indexed citations breakdown →
19.
Yan, Zijian, et al.. (2021). Jintiange Capsule May Have a Positive Effect on Pain Relief and Functional Activity in Patients with Knee Osteoarthritis: A Meta-Analysis of Randomized Trials. Evidence-based Complementary and Alternative Medicine. 2021. 1–11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026